iGMDRD571
Canonical SMILES: COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F
InChI: InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)
InChI Key: ONIQOQHATWINJY-UHFFFAOYSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
---|---|---|---|---|---|
Standard NameCabozantinib CHEMBLCHEMBL2105717 CHEMBL2103868 Pubchem CID25102800 DRUGBANK IDDB08875 Drug StatusAlone Drug TypeSmall Molecule |
Drug Class:
AmidesAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsHeterocyclic CompoundsHeterocyclic Compounds, 1-RingKinase InhibitorProtein Kinase InhibitorsReceptor Protein-Tyrosine Kinases, antagonists & inhibitorsVascular Endothelial Growth Factor Receptor 2 AntagonistDrug Pathways:
Other, kinasesDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Cabozantinib
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |